M&T Bank Corp Aspira Women'S Health Inc. Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.3 - $0.41 $59,997 - $81,997	199,993 Added 399.93%	250,000 $82,000
Q4 2022 Feb 13, 2023	SELL	$0.3 - $0.41 $59,997 - $81,997	-199,993 Reduced 80.0%	50,007 $16,000
Q1 2022 May 09, 2022	BUY	$0.88 - $1.81 $44,000 - $90,500	50,000 Added 25.0%	250,000 $260,000
Q2 2020 Jul 29, 2020	BUY	$0.78 - $5.25 $156,000 - $1.05 Million	200,000 New	200,000 $768,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.